Literature DB >> 21030153

Validation of a Leishmania infantum ELISA rapid test for serological diagnosis of Leishmania chagasi in dogs.

M Marcondes1, A W Biondo, A A D Gomes, A R S Silva, R F C Vieira, A A Camacho, John Quinn, R Chandrashekar.   

Abstract

Canine visceral leishmaniasis (CVL) is caused by Leishmania donovani complex parasites including L. donovani, Leishmania infantum and Leishmania chagasi. As some studies suggest that L. chagasi and L. infantum may be very similar or even the same species, the aim of the present study was to evaluate a commercial rapid ELISA test, originally designed for L. infantum, in the diagnosis of CVL in dogs naturally infected by L. chagasi. A total of 400 serum canine samples, including 283 positive dogs for CVL from an endemic area, 86 clinically healthy dogs from a non-endemic area and 31 dogs seropositive for confounding infectious agents (Trypanosoma cruzi, Toxoplasma gondii, Neospora caninum, Babesia canis and Ehrlichia canis) were used for test validation. An overall sensitivity of 94.7% (95% CI=91.41-97.01%) and specificity of 90.6% (95% CI=83.80-95.21%) was found, with a high degree of agreement (k=0.8445) to the indirect ELISA. When confounding infectious diseases were excluded, specificity increased to 100% (95% CI=95.8-100%), with a higher degree of agreement (k=0.8928). In conclusion, the commercial kit designed for L. infantum was a highly sensitive and specific device for detection of L. chagasi infection in dogs, which indicates high immunoreactivity similarities between L. infantum and L. chagasi.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21030153     DOI: 10.1016/j.vetpar.2010.09.036

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  6 in total

Review 1.  A new Leishmania-specific hypothetical protein and its non-described specific B cell conformational epitope applied in the serodiagnosis of canine visceral leishmaniasis.

Authors:  Daniela P Lage; Vívian T Martins; Mariana C Duarte; Lourena E Costa; Esther Garde; Laura M Dimer; Amanda C S Kursancew; Miguel A Chávez-Fumagalli; Danielle F de Magalhães-Soares; Daniel Menezes-Souza; Bruno M Roatt; Ricardo A Machado-de-Ávila; Manuel Soto; Carlos A P Tavares; Eduardo A F Coelho
Journal:  Parasitol Res       Date:  2016-01-19       Impact factor: 2.289

2.  Subtractive phage display selection from canine visceral leishmaniasis identifies novel epitopes that mimic Leishmania infantum antigens with potential serodiagnosis applications.

Authors:  Lourena E Costa; Mayara I S Lima; Miguel A Chávez-Fumagalli; Daniel Menezes-Souza; Vivian T Martins; Mariana C Duarte; Paula S Lage; Eliane G P Lopes; Daniela P Lage; Tatiana G Ribeiro; Pedro H R Andrade; Danielle F de Magalhães-Soares; Manuel Soto; Carlos A P Tavares; Luiz R Goulart; Eduardo A F Coelho
Journal:  Clin Vaccine Immunol       Date:  2013-11-20

3.  Detection of Leishmania donovani infection using magnetic beads-based serum peptide profiling by MALDI-TOF MS in mice model.

Authors:  Lixia Li; Jiping Li; Hongtao Jin; Limin Shang; Bo Li; Feng Wei; Quan Liu
Journal:  Parasitol Res       Date:  2011-08-18       Impact factor: 2.289

4.  Seropositivity of main vector-borne pathogens in dogs across Europe.

Authors:  Guadalupe Miró; Ian Wright; Helen Michael; Wade Burton; Evan Hegarty; Jaume Rodón; Jesse Buch; Nikola Pantchev; Georg von Samson-Himmelstjerna
Journal:  Parasit Vectors       Date:  2022-06-06       Impact factor: 4.047

5.  Evaluation of a rapid device for serological diagnosis of Leishmania infantum infection in dogs as an alternative to immunofluorescence assay and Western blotting.

Authors:  E Ferroglio; S Zanet; W Mignone; M Poggi; A Trisciuoglio; P Bianciardi
Journal:  Clin Vaccine Immunol       Date:  2013-02-27

Review 6.  Wild and synanthropic reservoirs of Leishmania species in the Americas.

Authors:  André Luiz R Roque; Ana Maria Jansen
Journal:  Int J Parasitol Parasites Wildl       Date:  2014-08-29       Impact factor: 2.674

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.